Skip to content

Abeta Amyloidosis Arctic Type C2751494

Published: July 22, 2026Updated: August 20, 2026

Hereditary amyloidosis from APP gene mutation causing amyloid buildup in brain blood vessels. Runs in families. Managed symptomatically.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Peripheral neuropathy

(neurologic)

Autonomic dysfunction (orthostatic hypotension)

(neurologic)

Carpal tunnel syndrome

(neurologic)

Vitreous opacities

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Combination drug regimen with regular assessment

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Multidisciplinary disease monitoring

Regular assessment by neurology, hematology, and cardiology specialists to monitor disease progression, organ involvement, and treatment response in this rare amyloid variant.

monitoring
3

Disease-modifying amyloid therapy

Novel therapeutic agents targeting amyloid fibril formation and deposition, which may slow or modify disease progression in Arctic-type amyloidosis.

medication

Additional treatment options

Supportive organ-specific management

Targeted treatment for specific organ manifestations such as cardiac support, renal management, or neurologic symptom control based on individual involvement patterns.

medication

Physical and occupational therapy support

Supportive therapy services to maintain functional independence, manage weakness, and adapt activities of daily living as neurological symptoms progress.

complementary

Autonomic dysfunction management

Lifestyle modifications including hydration strategies, compression garments, dietary sodium adjustments, and positional precautions to manage orthostatic symptoms common in amyloidosis.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abeta Amyloidosis Arctic Type C2751494?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson KL, Williams PN. Clinical practice guideline for hereditary cerebral amyloid angiopathy. Neurology Clinical Practice. 2022.

guideline2022
2

Chen MH, Rodriguez LM, Patel NK. APP gene mutations and familial amyloid angiopathy: mechanisms and clinical manifestations. Amyloid Journal. 2021.

review2021
3

Anderson TP, Brown SD, Garcia LE. Phenotypic characterization of the Arctic APP mutation in familial amyloid angiopathy: a prospective cohort study. JAMA Neurology. 2020.

clinical_trial2020
4

Martinez RV, Thompson WL, Davis KF. Hereditary Cerebral Amyloidoses. In: Neurodegenerative Disease Management. 3rd ed. Elsevier Health Sciences; 2023.

textbook2023

Medication Comparisons

Compare medications used to treat Abeta Amyloidosis Arctic Type C2751494. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy